Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
3,85 USD | -7,00% | +22,40% | -22,55% |
23/04 | Sectorupdate: Gezondheidszorgaandelen stijgen laat in de middag | MT |
23/04 | Top Middag Decliners | MT |
Omzet 2024 * | 500K 468K | Omzet 2025 * | 22,83 mln. 21,37 mln. | Marktkapitalisatie | 113 mln. 106 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -60 mln. -56,17 mln. | Nettowinst (verlies) 2025 * | -63 mln. -58,98 mln. | EV/omzet 2024 * | 226 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 4,96 x |
K/w-verhouding 2024 * |
-1,94
x | K/w-verhouding 2025 * |
-2,18
x | Werknemers | 84 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 92,85% |
Recentste transcriptie over Abeona Therapeutics Inc.
1 dag | -7,00% | ||
1 week | +22,40% | ||
Lopende maand | -6,28% | ||
1 maand | -49,74% | ||
3 maanden | -9,77% | ||
6 maanden | +1,31% | ||
Lopend jaar | -22,55% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Vishwas Seshadri
CEO | Chief Executive Officer | 48 | 01-06-21 |
Michael Amoroso
CHM | Chairman | 46 | 09-07-20 |
Joseph Vazzano
DFI | Director of Finance/CFO | 40 | 14-03-22 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Mark Alvino
BRD | Director/Board Member | 56 | 01-03-06 |
Faith Charles
BRD | Director/Board Member | 62 | 25-03-21 |
Leila Alland
BRD | Director/Board Member | 61 | 19-04-21 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
01-05-24 | 3,89 | -6,04% | 480 712 |
30-04-24 | 4,14 | +20,35% | 2 229 204 |
29-04-24 | 3,44 | +5,52% | 2 099 991 |
26-04-24 | 3,26 | +2,19% | 1 210 920 |
25-04-24 | 3,19 | +0,63% | 1 104 119 |
uitgestelde koers Nasdaq, 01 mei 2024 om 16:53 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-22,55% | 113 mln. | |
-0,71% | 42,19 mld. | |
+44,30% | 40,15 mld. | |
-6,20% | 28,31 mld. | |
+5,52% | 24,63 mld. | |
-23,65% | 18,2 mld. | |
+26,93% | 12,01 mld. | |
-3,88% | 11,76 mld. | |
+14,74% | 10,4 mld. | |
-4,61% | 9,94 mld. |